Authors: Lohray, BB Lohray, VB Bajji, AC Kalchar, S Poondra, RR Padakanti, S Chakrabarti, R Vikramadithyan, RK Misra, P Juluri, S Mamidi, NVSR Rajagopalan, R

Citation: Bb. Lohray et al., (-)3-[4-[2-(phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropanoic acid [(-)DRF2725]: A dual PPAR agonist with potent antihyperglycemic and lipid modulating activity, J MED CHEM, 44(16), 2001, pp. 2675-2678

Authors: Vikramadithyan, RK Chakrabarti, R Misra, P Premkumar, M Kumar, SKB Rao, CS Ghosh, A Reddy, KN Uma, C Rajagopalan, R

Citation: Rk. Vikramadithyan et al., Euglycemic and hypolipidemic activity of PAT5A: A unique thiazolidinedionewith weak peroxisome proliferator activated receptor gamma activity, METABOLISM, 49(11), 2000, pp. 1417-1423

Authors: Lohray, BB Bhushan, V Reddy, AS Rao, PB Reddy, NJ Reddy, KA Vikramadithyan, RK Rajagopalan, R

Citation: Bb. Lohray et al., Novel euglycemic and hypolipidemic agents: Pyridine containing unsaturatedthiazolidinediones, I J CHEM B, 38(4), 1999, pp. 403-406

Authors: Reddy, KA Lohray, BB Bhushan, V Reddy, AS Mamidi, NVSR Reddy, PP Saibaba, V Reddy, NJ Suryaprakash, A Misra, P Vikramadithyan, RK Rajagopalan, R

Citation: Ka. Reddy et al., Novel antidiabetic and hypolipidemic agents. 5. Hydroxyl versus benzyloxy containing chroman derivatives, J MED CHEM, 42(17), 1999, pp. 3265-3278

Authors: Chakrabarti, R Vikramadithyan, RK Dileepkumar, T Kumar, KBS Kumar, MP Misra, P Rao, PB Lohray, VB Lohray, BB Rajagopalan, R

Citation: R. Chakrabarti et al., Studies an the euglycemic and hypolipidemic potentials of the novel indoleanalogue of thiazolidinedione, DRF 2189, ARZNEI-FOR, 49(11), 1999, pp. 905-911